ADA-011

N/A

Report date: 2025/02/02 20:00:08
NME

Base Information

Drug NameADA-011
Drug Alias NameADA-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte immunoglobulin-like receptors antagonists
TargetsLeukocyte immunoglobulin-like receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdanate Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdanate Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A